Production and Platform Technologies

A key requirement from global regulators is that drug developers comply with Good Manufacturing Practice (GMP) in their production facilities. One of the oldest and best known companies supporting the construction and development of such facilities is Vogelbusch. A worldwide provider of innovative solutions for the biotechnology industry, Vogelbusch plans and builds plants for the biopharmaceutical industry.

ZETA is an owner-operated Austrian company and a leading international supplier of customised solutions for liquid processes in the biotechnology, pharmaceutical and food sectors.
is an owner-operated Austrian company and a leading international supplier of customised solutions for liquid processes in the biotechnology, pharmaceutical and food sectors.

VTU Engineering is an expert in the construction of pharmaceutical plants. VTU Technology is a leading contract research and development company providing services for the fast-track generation of high performance, industrial protein production strains and processes. VTU uses its technical know-how across a wide variety of areas such as API synthesis, fermentation with cells, blood plasma fractioning, lyophilisation or treatment of exhaust air.

The GMP manufacture of biological materials has to be conducted in such a way that no contaminants are introduced and the highest standards of biosafety are maintained. ViruSure specialises in testing for contaminants, allowing quality assurance of the highest standard. ViruSure is a specialist in virus and prion safety testing of biopharmaceutical products at GMP and GLP standards. Another specialist in the removal of prion and viral contamination is HÄMOSAN offering services in transfer and performance of purification protocols and validation experiments.

Evercyte focuses on the acceleration and cost reduction of drug discovery and development by introducing the concept of “pharmacocellomics™”. The company develops, manufactures and commercialises various single cell lines or panels of immortalised human cell strains for drug screening purposes.

With established drug developers comes a need for outside support from suppliers, service providers and platforms. Austria has met the challenge with a plethora of businesses and related service providers such as suppliers of clean rooms, preclinical research facilities, reagents, prion testing, essential basic materials including glassware right up to GMP plants and GCP quality assurance. There is enough diversity in the Austrian industry to build supplier networks that are never more than one flight hour apart and can truly be labelled “Made in Austria”.

For companies looking to outsource production, Austria has its own home-grown Contract Manufacturing Organisations (CMOs) as well. Biomay, for example, is certified for GMP manufacturing of biopharmaceuticals such as recombinant proteins, plasmid DNA, allergens and antibody fragments which are produced in E. coli or other microbial expression systems. In the field of plasmid DNA manufacturing, Biomay offers CMO services which are based on Boehringer Ingelheim’s validated pDNA production technology.

Validogen develops high performance expression strains and economically viable protein production processes for the manufacture of biopharmaceuticals, enzymes and various other recombinant proteins. Founded in 2008, the company emerged to a globally recognized player in the field of Pichia pastoris based protein expression. It develops high performance expression strains and economically viable protein production processes for the manufacture of biopharmaceuticals, enzymes and various other recombinant proteins. Founded in 2008, the company emerged to a globally recognized player in the field of Pichia pastoris based protein expression.

Polymun is developing and manufacturing a whole range of biopharmaceuticals as well as liposomal formulations.

Since 1945, Montavit’s international business is focused on the production and distribution of pharmaceuticals and associated health related products. We are interested in sustainable and successful development of our business to safeguard our independence as a family owned company. For this reason, sustainability is a core feature of our business strategy. We have strong own brands which stimulate customer loyalty for our products and a number of reputable contract manufacturing partners.

EUCODIS Bioscience on the other hand, is an application-driven, enzyme-engineering company with customers in the pharmaceutical, biotechnology, diagnostics and other industries.

At the very end of the pharmaceutical value chain, when products are ready to be positioned for the market, are companies such as ABF Pharmaceutical Services part of the GBA Group. ABF is a GMP accredited specialist in labelling, packing, storage and distribution of Investigational Medicinal Products as well as a provider of central lab services.